Beyond Risk Management, Inc. – Trademark Portfolio
Entity Type: 03
Beyond Risk Management, Inc. holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 21 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 10 trademarks are registered and 11 are pending. Notable registered marks include BEVCAP, EIRION, ORIGIN, BEYOND RISK, and BEYOND HEALTH. The owner is based in Phoenix, AZ.
Suite 400
3101 N. Central Ave.
Phoenix, AZ 85012
Showing of trademarks Trademarks
Trademark Classifications
Beyond Risk Management, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Beyond Risk Management, Inc. have?
Beyond Risk Management, Inc. has 21 U.S. trademarks filed with the USPTO. Of these, 10 registered, 11 pending.
What trademark classes does Beyond Risk Management, Inc. file in?
Beyond Risk Management, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Beyond Risk Management, Inc.'s most well-known trademarks?
Beyond Risk Management, Inc.'s registered trademark portfolio includes well-known marks such as BEVCAP, EIRION, ORIGIN, BEYOND RISK, and BEYOND HEALTH. These are among 10 currently registered trademarks in the portfolio.
What is Beyond Risk Management, Inc.'s trademark registration success rate?
Beyond Risk Management, Inc. has a 100% trademark registration rate, with 10 out of 10 resolved applications resulting in successful registration. Currently, 11 applications are pending review.